Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
about
Adjuvant radiotherapy following radical prostatectomy for prostate cancerA mathematical model for interpretable clinical decision support with applications in gynecology.External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets.Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting.Critical review of prostate cancer predictive toolsA nomogram for individualized estimation of survival among patients with brain metastasisInitial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing.Systematic review of clinical features of suspected prostate cancer in primary care.Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean menPre-operative prediction of advanced prostatic cancer using clinical decision support systems: accuracy comparison between support vector machine and artificial neural network.The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.Visualizing Risk Prediction ModelsOptimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.External validation of extended prostate biopsy nomogram.Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD ScoreDevelopment and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian CohortIntegrated predictive model for prostatic cancer using clinical, laboratory and ultrasound data.Testosterone replacement therapy and the risk of prostate cancer. Is there a link?A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL.Risk stratification in prostate cancer screening.The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.Prostate cancer nomograms: a review of their use in cancer detection and treatment.Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary series.Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Can the prostate risk calculator based on Western population be applied to Asian population?A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.An abnormal digital rectal examination is an independent predictor of Gleason > or =7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men.Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.Internal validation of an artificial neural network for prostate biopsy outcome.Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models.Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.Low serum neutrophil count predicts a positive prostate biopsy.Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?Clinico-pathological Correlation of Digital Rectal Examination Findings Amongst Nigerian Men with Prostatic Diseases: A Prospective Study of 236 Cases.
P2860
Q24234347-30BED4E4-D86D-4976-B47C-11D8DBA1F2BEQ27305268-9B44A292-D787-4A48-A7CA-34C1FE77420CQ31096808-4AD613A3-CD29-4086-BACF-B74AE1D5E3E3Q33410362-CA28A73D-C6DE-4316-81BC-D81819F1DDB2Q34027912-795C6638-1C4D-49D5-9840-D75B1C0404F5Q34104562-43CFB2E6-29D1-45CB-92A5-6AEDE3FFE693Q34250819-6D8F846C-5F71-4A18-A24E-C51525C2875AQ34451940-7393B89E-707E-4243-9C62-819BAE2995B9Q34994815-5251A802-CAA0-4292-9447-042C82155488Q35141766-2CA58180-C053-48A9-AE7C-C898C83C5805Q35201725-7AAEB872-70DA-4990-948F-F5531A5496C0Q35532150-66581D60-1F4F-4CC3-8CA0-3FCF445E1D5DQ35692218-39827E47-73E9-4CC5-ACED-50573EADB0ABQ35771276-4ECC9400-F9DF-404C-8E80-4FD22EA8E5E0Q35921555-49C7E0C9-C110-4969-ADBF-B8923B02BA34Q35924515-ED3E7117-BFD9-45EA-B27F-23F10CEE6B9EQ36236472-BABC1FC5-93DD-440A-A58C-4FC224644B37Q36238237-4C94DBEF-56F5-4389-B049-7F9D89CB6F16Q36300978-DBF2C1EC-DABE-481B-91C5-D995BAEBE3DEQ36310652-884C7FFD-CF7E-48F0-9F9D-5B7656E92A7DQ37084150-DDD0E34D-6536-42A8-B699-48D40B38E305Q37622189-ACEFEA1B-BC3E-4AB2-BCDC-A12951D2E966Q38068114-B245BC71-3480-4170-B887-8FB0E32160DCQ38165242-7EB1A62A-FCDF-4FDB-BBB3-667237E25DAEQ38181000-ECA9E368-8B5F-4D2F-ADC8-31FAB88710B7Q38219393-04F094A9-0929-4C7B-AA16-0CADBE00153BQ38268839-482B4BEE-2E42-45DD-A69B-7E748B9A7D22Q38471448-38F9786D-C410-440A-93B6-876DA18A0B7DQ39213559-27046A27-F43A-4FFB-94C4-1B75CA80D826Q39761758-ACB63C09-D005-449C-BBB2-9BBAE38478D1Q39777849-89869E51-344A-4862-8C42-22D0D82FF6ACQ39845544-A1BAEB1C-CF77-451F-B460-97F6C8CE005BQ39904254-3985525F-D7C5-4D2D-9734-EC1BDB267B66Q39908377-0DC84074-C5B4-41F0-AC06-4795E53B73C7Q39932994-C8BCE074-E007-4BFA-BB0A-166573AC3E9DQ40010533-7E5B1E59-62DE-41A6-A874-6C9F1F898FA8Q40014386-8772A7CB-DDD4-405A-A682-3ADAC67C4B33Q40047637-08A71B89-8EBB-4982-94BB-3DB66591425DQ40087634-747F96E2-E757-465B-A712-A75768010830Q40136506-6F7228ED-A0F1-43A5-B017-11F5D92A978E
P2860
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Development and validation of ...... rum prostate specific antigen.
@en
Development and validation of ...... rum prostate specific antigen.
@nl
type
label
Development and validation of ...... rum prostate specific antigen.
@en
Development and validation of ...... rum prostate specific antigen.
@nl
prefLabel
Development and validation of ...... rum prostate specific antigen.
@en
Development and validation of ...... rum prostate specific antigen.
@nl
P2093
P2860
P1476
Development and validation of ...... rum prostate specific antigen.
@en
P2093
Armen G Aprikian
Hans Heinzer
Hartwig Huland
Ilias Cagiannos
Luc Valiquette
Markus Graefen
Michael W Kattan
Paul Perrotte
Peter T Scardino
Pierre I Karakiewicz
P2860
P304
P356
10.1097/01.JU.0000158039.94467.5D
P407
P577
2005-06-01T00:00:00Z